ProfileGDS4718 / 226492_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 97% 80% 95% 96% 82% 79% 96% 97% 95% 96% 95% 87% 45% 80% 77% 94% 68% 26% 36% 92% 93% 95% 93% 90% 74% 96% 46% 95% 77% 75% 69% 97% 95% 45% 48% 88% 96% 95% 74% 94% 47% 73% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.480395
GSM549102patient 115, normal, homogenized [OPG study]10.961697
GSM549104patient 119, normal, homogenized [OPG study]7.933680
GSM549108patient 138, normal, homogenized [OPG study]10.193195
GSM549119patient 077, normal, homogenized [OPG study]10.505196
GSM549133patient 032, cancer, homogenized [OPG study]8.2364382
GSM549139patient 042, cancer, homogenized [OPG study]7.7993379
GSM549099patient 107, normal, homogenized [OPG study]10.42596
GSM549109patient 139, normal, homogenized [OPG study]11.150197
GSM549110patient 046, normal, homogenized [OPG study]10.45395
GSM549114patient 063, normal, homogenized [OPG study]10.841796
GSM549122patient 082, normal, homogenized [OPG study]10.42395
GSM549134patient 033, cancer, homogenized [OPG study]8.7883687
GSM549136patient 036, cancer, homogenized [OPG study]5.2098645
GSM549140patient 044, cancer, homogenized [OPG study]7.9580780
GSM549111patient 047, normal, homogenized [OPG study]7.5932677
GSM549113patient 057, normal, homogenized [OPG study]10.140594
GSM549132patient 031, cancer, homogenized [OPG study]6.7364868
GSM549137patient 038, cancer, homogenized [OPG study]4.353326
GSM549142patient 047, cancer, homogenized [OPG study]4.9302336
GSM549100patient 110, normal, homogenized [OPG study]9.4531492
GSM549107patient 135, normal, homogenized [OPG study]9.7893193
GSM549115patient 068, normal, homogenized [OPG study]10.596795
GSM549116patient 072, normal, homogenized [OPG study]9.9533793
GSM549120patient 078, normal, homogenized [OPG study]9.1566490
GSM549131patient 030, cancer, homogenized [OPG study]7.364574
GSM549118patient 074, normal, homogenized [OPG study]10.676796
GSM549129patient 027, cancer, homogenized [OPG study]5.2922546
GSM549123patient 088, normal, homogenized [OPG study]10.22695
GSM549124patient 006, cancer, homogenized [OPG study]7.4401577
GSM549126patient 015, cancer, homogenized [OPG study]7.3303975
GSM549128patient 025, cancer, homogenized [OPG study]6.8748169
GSM549103patient 117, normal, homogenized [OPG study]11.160497
GSM549117patient 073, normal, homogenized [OPG study]10.496895
GSM549138patient 041, cancer, homogenized [OPG study]5.2456645
GSM549141patient 045, cancer, homogenized [OPG study]5.3787648
GSM549130patient 028, cancer, homogenized [OPG study]8.835688
GSM549101patient 111, normal, homogenized [OPG study]10.549896
GSM549105patient 128, normal, homogenized [OPG study]10.13695
GSM549106patient 134, normal, homogenized [OPG study]7.3511674
GSM549112patient 048, normal, homogenized [OPG study]10.154794
GSM549125patient 011, cancer, homogenized [OPG study]5.3734447
GSM549127patient 024, cancer, homogenized [OPG study]7.2325773
GSM549135patient 035, cancer, homogenized [OPG study]5.1181644